Financial News
KILL Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™
By:
Business Wire
April 17, 2025 at 21:03 PM EDT
Aditxt, Inc. requests that their press release NewsItemId: 20250417385764 “Dr. Charles Howe of the Mayo Clinic’s Neuroimmunology Department to Join Aditxt Weekly Update on May 2, 2025, to Discuss Newly Announced Preclinical Study Results Sponsored by Aditxt’s Subsidiary Adimune™” be killed.
The release was issued in error by Aditxt, Inc..
A replacement release will not be issued at this time.
Contacts
Aditxt, Inc.
Corporate Communications
Jeff Ramson, PCG Advisory, Inc.
T: 646-863-6893
contactus@aditxt.com
More News
View More
Tencent Music Stock Outshines Spotify as China’s Music Giant
Today 9:30 EDT
DICKS’s Sporting Goods Stock Dropped After Earnings—Is It a Buy?
August 30, 2025
Via MarketBeat
Tickers
DKS
Engines to AI: Cummins’ Surprising Growth Driver
August 30, 2025
Smaller Industrials Names Seeing Surging Growth: Here's Why
August 30, 2025
MarketBeat Week in Review – 08/25 - 08/29
August 30, 2025
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.